From 'Killing Cancer with Poison' to Molecular Targeted, Immunotherapy, and Personalized MedicineThe history of anticancer ...

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages Northwestern University economist ...

ABC News' correspondent Will Reeve is opening up for the first time about receiving a cancer diagnosis just months after ...

ImpriMed, a precision medicine company using artificial intelligence and live-cell testing to inform cancer treatment decisions, today announced a new cost analysis highlighting the value of its ...

The application is supported by the phase 3 SAFFRON trial, in which savolitinib plus osimertinib improved progression-free ...

Reeve opens up about a deeply personal health battle he’s been facing for months and shares why he chose to make his journey ...

Instead of capturing a memory with an iPhone camera, Carnegie Mellon University's Nivedita Shyamsundar used hers to make a ...

Bangladesh's pharmaceutical industry has moved from import dependence to near self-sufficiency, making critical medicines ...

ABC News correspondent Will Reeve, the son of Superman actor Christopher Reeve, has revealed that he was diagnosed with ...

South Korea expands insurance to cover three cancer drugs and first combo Coverage widens from October for Retsevmo, Vyloy, ...

BeyondSpring Inc. announced that the U.S. Food and Drug Administration (?FDA?) has granted Fast Track designation to Plinabulin and docetaxel for the treatment of patients with advanced or metastatic ...

HUTCHMED said Tuesday that partner AstraZeneca (AZN) has submitted a New Drug Application to the US Food and Drug Administration for the lung-cancer fighting drugs Orpathys plus T ...